PL413155A1 - Nanokapsułka do przenoszenia zwiazku lipofilowego i sposób jej wytwarzania - Google Patents

Nanokapsułka do przenoszenia zwiazku lipofilowego i sposób jej wytwarzania

Info

Publication number
PL413155A1
PL413155A1 PL413155A PL41315515A PL413155A1 PL 413155 A1 PL413155 A1 PL 413155A1 PL 413155 A PL413155 A PL 413155A PL 41315515 A PL41315515 A PL 41315515A PL 413155 A1 PL413155 A1 PL 413155A1
Authority
PL
Poland
Prior art keywords
nanocapsule
lipophile
transferring
compound
producing
Prior art date
Application number
PL413155A
Other languages
English (en)
Other versions
PL229276B1 (pl
Inventor
Szczepan Zapatoczny
Joanna Szafraniec
Original Assignee
Uniwersytet Jagielloński
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniwersytet Jagielloński filed Critical Uniwersytet Jagielloński
Priority to PL413155A priority Critical patent/PL229276B1/pl
Priority to MX2018000637A priority patent/MX387005B/es
Priority to HK18110566.3A priority patent/HK1251154B/zh
Priority to RU2018103323A priority patent/RU2723374C1/ru
Priority to US15/743,728 priority patent/US10821083B2/en
Priority to KR1020187004688A priority patent/KR20180025318A/ko
Priority to EP16757368.2A priority patent/EP3324939A1/en
Priority to CA2992705A priority patent/CA2992705A1/en
Priority to CN201680042159.7A priority patent/CN107847441B/zh
Priority to JP2018501907A priority patent/JP6971217B2/ja
Priority to AU2016295949A priority patent/AU2016295949A1/en
Priority to PCT/PL2016/050032 priority patent/WO2017014655A1/en
Publication of PL413155A1 publication Critical patent/PL413155A1/pl
Publication of PL229276B1 publication Critical patent/PL229276B1/pl
Priority to US16/932,369 priority patent/US20200345651A1/en
Priority to AU2021240279A priority patent/AU2021240279A1/en
Priority to AU2024201288A priority patent/AU2024201288A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5161—Polysaccharides, e.g. alginate, chitosan, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5176—Compounds of unknown constitution, e.g. material from plants or animals

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Botany (AREA)
  • Zoology (AREA)
  • Medicinal Preparation (AREA)
  • Manufacturing Of Micro-Capsules (AREA)
  • Cosmetics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

Ujawniono biokompatybilne polisacharydowe kapsuły na ciekłych olejowych rdzeniach o średnicach nie przekraczających 1 µm, stabilizowane bez konieczności stosowania małocząsteczkowych surfaktantów, charakteryzujące się efektywną enkapsulacją związków hydrofobowych i wysoką stabilnością w wodnej zawiesinie. Przedmiotem zgłoszenia jest także sposób ich wytwarzania i stabilizacji za pomocą modyfikowanych hydrofobowo sacharydów obdarzonych trwałym ładunkiem elektrostatycznym.
PL413155A 2015-07-17 2015-07-17 Nanokapsuła do przenoszenia związku lipofilowego i sposób jej wytwarzania PL229276B1 (pl)

Priority Applications (15)

Application Number Priority Date Filing Date Title
PL413155A PL229276B1 (pl) 2015-07-17 2015-07-17 Nanokapsuła do przenoszenia związku lipofilowego i sposób jej wytwarzania
CA2992705A CA2992705A1 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof
CN201680042159.7A CN107847441B (zh) 2015-07-17 2016-07-12 用于递送亲脂性化合物的纳米胶囊及其制备方法
RU2018103323A RU2723374C1 (ru) 2015-07-17 2016-07-12 Нанокапсула для доставки липофильного соединения и способ ее получения
US15/743,728 US10821083B2 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof
KR1020187004688A KR20180025318A (ko) 2015-07-17 2016-07-12 친유성 화합물 전달용 나노캡슐 및 그 제조 방법
EP16757368.2A EP3324939A1 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof
MX2018000637A MX387005B (es) 2015-07-17 2016-07-12 Nanocápsula para la administración de un compuesto lipófilo y proceso de preparación de la misma.
HK18110566.3A HK1251154B (zh) 2015-07-17 2016-07-12 用於递送亲脂性化合物的纳米胶囊及其制备方法
JP2018501907A JP6971217B2 (ja) 2015-07-17 2016-07-12 親油性化合物を送達するためのナノカプセルおよびその調製プロセス
AU2016295949A AU2016295949A1 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof
PCT/PL2016/050032 WO2017014655A1 (en) 2015-07-17 2016-07-12 Nanocapsule for delivery of lipophilic compound and process of preparation thereof
US16/932,369 US20200345651A1 (en) 2015-07-17 2020-07-17 Nanocapsule for delivery of lipophilic compound and process of preparation thereof
AU2021240279A AU2021240279A1 (en) 2015-07-17 2021-09-30 Nanocapsule for Delivery of Lipophilic Compound and Process of Preparation Thereof
AU2024201288A AU2024201288A1 (en) 2015-07-17 2024-02-27 Nanocapsule for Delivery of Lipophilic Compound and Process of Preparation Thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL413155A PL229276B1 (pl) 2015-07-17 2015-07-17 Nanokapsuła do przenoszenia związku lipofilowego i sposób jej wytwarzania

Publications (2)

Publication Number Publication Date
PL413155A1 true PL413155A1 (pl) 2017-01-30
PL229276B1 PL229276B1 (pl) 2018-06-29

Family

ID=56801756

Family Applications (1)

Application Number Title Priority Date Filing Date
PL413155A PL229276B1 (pl) 2015-07-17 2015-07-17 Nanokapsuła do przenoszenia związku lipofilowego i sposób jej wytwarzania

Country Status (11)

Country Link
US (2) US10821083B2 (pl)
EP (1) EP3324939A1 (pl)
JP (1) JP6971217B2 (pl)
KR (1) KR20180025318A (pl)
CN (1) CN107847441B (pl)
AU (3) AU2016295949A1 (pl)
CA (1) CA2992705A1 (pl)
MX (1) MX387005B (pl)
PL (1) PL229276B1 (pl)
RU (1) RU2723374C1 (pl)
WO (1) WO2017014655A1 (pl)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL425141A1 (pl) * 2018-04-06 2019-10-07 Uniwersytet Jagielloński Nanokapsuła z ciekłym rdzeniem olejowym, sposób jej wytwarzania oraz zastosowanie

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2018176047A (ja) * 2017-04-10 2018-11-15 パナソニックＩｐマネジメント株式会社 マイクロカプセル及びマイクロカプセルの製造方法、並びに、化粧料及び化粧料の製造方法
CN109535430A (zh) * 2017-09-22 2019-03-29 天津大学 一种油酰化壳寡糖胍接枝聚乙烯亚胺的两亲性衍生物及其制备方法
ES2711669A1 (es) * 2017-11-02 2019-05-06 Univ Santiago Compostela Sistemas de liberacion de farmacos de acido polisialico y metodos
CN108246215B (zh) * 2017-12-21 2020-06-30 四川大学 一种超薄壁壳聚糖微囊及其制备方法
CN108739807B (zh) * 2018-06-21 2021-07-13 中国热带农业科学院农产品加工研究所 植物油酸-壳聚糖基纳米微胶囊农药、其制备方法及其应用
WO2020036501A1 (en) * 2018-08-17 2020-02-20 Smela Krysztof Multicompartment system of nanocapsule-in-nanocapsule type, for encapsulation of a lipophilic and hydrophilic compound, and the related production method
CN109925983B (zh) * 2019-03-08 2021-12-28 紫罗兰家纺科技股份有限公司 基于乳木果油的双层微胶囊及其整理到纺织面料中的方法
CN111920782B (zh) * 2019-05-13 2025-11-18 中国医学科学院药物研究所 复合脂质纳米囊组合物及其制备方法和应用
CN112300767B (zh) * 2020-09-22 2022-04-05 山东大学 一种绿色靶向微胶囊及制备体系、制备方法和应用
PL4321175T3 (pl) 2022-08-11 2025-12-22 Chde Polska S.A. Magnetyczne nanokapsuły polimerowe nadające się do stosowania w terapii, zwłaszcza antynowotworowej
PL446441A1 (pl) * 2023-10-20 2025-04-22 Chde Polska Spółka Akcyjna 2-metylo-3-fitylo-1,4-naftochinon do stosowania w leczeniu lub zapobieganiu chorób przebiegających z dysfunkcją śródbłonka naczyniowego

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2093562B1 (es) 1995-05-26 1997-07-01 Univ Santiago Compostela Estabilizacion de sistemas coloidales mediante formacion de complejos ionicos lipido-polisacarido.
US20060063676A1 (en) 2004-09-17 2006-03-23 Brigance Mickey R Method for enhancing deposition of an agrochemical
CA2618974C (en) 2005-08-09 2014-01-28 Nanobio Corporation Nanoemulsion compositions having anti-inflammatory activity
JP5403585B2 (ja) * 2006-01-23 2014-01-29 イッサム リサーチ ディベロップメント カンパニー オブ ザ ヘブライ ユニバーシティー オブ エルサレム 活性薬剤用のデリバリーシステム
PT1834635E (pt) * 2006-03-13 2011-10-13 Advanced In Vitro Cell Technologies S L Sistemas estáveis de nanocápsula para a administração de moléculas activas
EP2266546A1 (en) 2009-06-08 2010-12-29 Advancell Advanced in Vitro Cell Technologies,S.A. Process for the preparation of colloidal systems for the delivery of active compounds
CN102161729B (zh) * 2011-02-25 2013-01-16 上海交通大学 水溶性多糖与疏水性单体形成纳米粒子的制备方法
ES2366255B2 (es) 2011-06-27 2012-08-08 Universidade De Santiago De Compostela Nanocomposiciones sacarídicas para la liberación de vacunas.
RU2494728C1 (ru) * 2012-08-16 2013-10-10 Федеральное государственное унитарное предприятие "Государственный научный центр "Научно-исследовательский институт органических полупродуктов и красителей" (ФГУП "ГНЦ "НИОПИК") Наноэмульсия, содержащая биологически активное вещество
CZ304654B6 (cs) * 2012-11-27 2014-08-20 Contipro Biotech S.R.O. Nanomicelární kompozice na bázi C6-C18-acylovaného hyaluronanu, způsob přípravy C6-C18-acylovaného hyaluronanu, způsob přípravy nanomicelární kompozice a stabilizované nanomicelární kompozice a použití
JP2016531112A (ja) * 2013-07-25 2016-10-06 ネムコア メディカル イノベーションズ インコーポレイテッド 疎水性白金誘導体のナノエマルジョン

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL425141A1 (pl) * 2018-04-06 2019-10-07 Uniwersytet Jagielloński Nanokapsuła z ciekłym rdzeniem olejowym, sposób jej wytwarzania oraz zastosowanie
WO2019194692A1 (en) * 2018-04-06 2019-10-10 Uniwersytet Jagielloński Nanocapsule with liquid oil core, its preparation method and application

Also Published As

Publication number Publication date
MX2018000637A (es) 2018-09-06
AU2024201288A1 (en) 2024-03-14
US20200345651A1 (en) 2020-11-05
HK1251154A1 (zh) 2019-01-25
EP3324939A1 (en) 2018-05-30
MX387005B (es) 2025-03-12
CA2992705A1 (en) 2017-01-26
US20180200197A1 (en) 2018-07-19
KR20180025318A (ko) 2018-03-08
WO2017014655A1 (en) 2017-01-26
US10821083B2 (en) 2020-11-03
RU2723374C1 (ru) 2020-06-10
CN107847441A (zh) 2018-03-27
JP2018523642A (ja) 2018-08-23
AU2016295949A1 (en) 2018-02-01
JP6971217B2 (ja) 2021-11-24
AU2021240279A1 (en) 2021-10-28
CN107847441B (zh) 2021-08-13
PL229276B1 (pl) 2018-06-29

Similar Documents

Publication Publication Date Title
PL413155A1 (pl) Nanokapsułka do przenoszenia zwiazku lipofilowego i sposób jej wytwarzania
NZ755923A (en) Storage-stable formulations
Keaveny Fluctuating force-coupling method for simulations of colloidal suspensions
MX2017015475A (es) Mejoras en o con relacion a composiciones encapsuladas de perfume.
CL2015000502A1 (es) Nanoparticula polimerica de finasterida, suspension acuosa conteniendo a la misma, composicion para tratamiento de alopecia, proceso de preparacion de dicha composicion, y su uso.
PE20160623A1 (es) Metodos para regular, u optimizar o mejorar el ph de un suelo
BR112012026941A2 (pt) processos para reduzir o tamanho de um ingrediente farmacêutico ativo, e para fabricar uma composição farmacêutica, ingrediente farmacêutico ativo, composição farmacêutica
WO2015185023A3 (zh) 一种载体颗粒及其制备方法
SG10201803430SA (en) Stable formulation of insulin glulisine
MX2019005710A (es) Particulados esfericos a base de silice y metodos para su preparacion.
GB2517881A (en) Reservoir wellbore fluid
MY177770A (en) Method for stabilizing a cavity in a well
MX2017014698A (es) Suspension de microcapsulas.
EP3287786A3 (en) Compositions and methods for active surveillance of prostate cancer
MX2016012641A (es) Dispersiones solidas secas en aceite en agua por aspersion para inhalacion de ingredientes farmaceuticos activos.
PH12016500794A1 (en) Aqueous suspension preparations and their use as leaf fertilizers
BR112017006443A2 (pt) partículas de propante formadas a partir de gotículas em suspensão e métodos de uso
HK1220120A1 (zh) 制造注射蛋白质微粒悬浮液的方法
FR3034683B1 (fr) Suspension stable de nanofils d'argent et son procede de fabrication
RU2013124525A (ru) Способ получения частиц инкапсулированного жирорастворимой полимерной оболочкой унаби, обладающего супрамолекулярными свойствами
FR3014874B1 (fr) Agent epaississant hydrosoluble pour systemes aqueux, formulations le contenant et utilisations
RU2013131625A (ru) Способ получения частиц инкапсулированного жирорастворимой полимерной оболочкой унаби, обладающего супрамолекулярными свойствами
Raffa et al. A uniform invariance principle for periodic systems with applications to synchronization
EA202090430A1 (ru) Способ получения продуктов из черного чая
RU2013131618A (ru) Способ получения частиц инкапсулированных жирорастворимой полимерной оболочкой солей металлов, обладающих супрамолекулярными свойствами